Author:
Tiirola Terttu,Jauhiainen Matti,Erkkilä Leena,Bloigu Aini,Leinonen Maija,Haasio Kristiina,Laitinen Kirsi,Saikku Pekka
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference8 articles.
1. Evidence for infectious agents in cardiovascular disease and atherosclerosis;Leinonen;Lancet Infect Dis,2002
2. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis;Laurila;Arterioscler Thromb Vasc Biol,1997
3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349–57.
4. Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice;Erkkilä;Antimicrob Agents Chemother,2005
5. Anti-inflammatory and immunomodulatory effects of statins;Blanco-Colio;Kidney Int,2003
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献